ILLUMINATING DRUG DISCOVERY LIMITED
MERCANTILE CHAMBERS C/O A WILSON - NELSON GILMOUR SMITH, 53 BOTHWELL STREET, GLASGOW  G2 6TB- Active
- Private Limited Company
- Company No. SC728661
- Last Updated: 01 Mar 2024
Company Profile
ILLUMINATING DRUG DISCOVERY LIMITED was incorporated on Tuesday, April 5, 2022 as a Private Limited Company with registered address in GLASGOW. ILLUMINATING DRUG DISCOVERY LIMITED has the status: Active and it's listed in the following category: Other service activities n.e.c.. This Private Limited Company has been operating for 2 years 7 months and 9 days.
Name | ILLUMINATING DRUG DISCOVERY LIMITED |
---|---|
Company number | SC728661 |
Company type | Private Limited Company |
Incorporation date | 05 Apr 2022 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
MERCANTILE CHAMBERS C/O A WILSON - NELSON GILMOUR SMITH 53 BOTHWELL STREET GLASGOW G2 6TB |
---|---|
Country Of Origin | SCOTLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mrs Maureen Wooster Nationality: British,American |
Dates: Tuesday, April 5, 2022 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Dr Richard Wooster Nationality: British,American |
Dates: Tuesday, April 5, 2022 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 30 April |
Next annual accounts due | 31 January 2025, (77 days left) |
Latest accounts | 30 April 2023 |
Next confirmation statement due | 03 May 2023 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against ILLUMINATING DRUG DISCOVERY LIMITED.
Previous Names
Name | Change Date |
---|---|
ILLUMINATING DRUG DISCOVERY LIMITED | 05 Apr 2022 |